PD‐L1 expression downregulation by RNF43 in gastric carcinoma enhances antitumour activity of T cells

Author:

Yang Jing1,Wei Meng23,Liu Xin4,Shao Xiao5,Yan Jingshuang1,Liu Jialong6,Wen Jing7,Zhang Xueting1,Dong Ruihua8,Min Min1ORCID

Affiliation:

1. Department of Gastroenterology the First Medical Center of Chinese PLA General Hospital Beijing China

2. Department of Hepatobiliary Surgery Affiliated Tumor Hospital of Guangxi Medical University Nanning China

3. Key Laboratory of High‐Incidence‐Tumor Prevention and Treatment (Guangxi Medical University) Ministry of Education Nanning China

4. Department of Laboratory Medicine the Eighth Medical Center of Chinese PLA General Hospital Beijing China

5. Department of Pharmacology the Fifth Medical Center of Chinese PLA General Hospital Beijing China

6. Beijing Institute of Biotechnology Academy of Military Medical Sciences (AMMS) Beijing China

7. Department of Gastroenterology Chinese PLA 984 Hospital Beijing China

8. Department of Research Ward Beijing Friendship Hospital, Capital Medical University Beijing China

Abstract

AbstractRing finger protein 43 (RNF43), a transmembrane E3 ubiquitin ligase, has been indicated to be a potential biomarker for gastric cancer treatment, as this protein increases tumour cell apoptosis and suppresses cellular proliferation. The role of RNF43 in cellular immunotherapy remains unclear. Herein, we aimed to explore the expression level of RNF43 in gastric cancer cell lines and its role in cellular immunotherapy. The expression level of RNF43 and PD‐L1 and their correlation in gastric cancer cell lines were analysed. The expression of PD‐L1 was negatively correlated with that of RNF43 in gastric cancer cell lines. RNF43 interacted with PD‐L1 to augment both K48‐ and K63‐linked ubiquitination of PD‐L1 in gastric cancer cell lines. In addition, RNF43 expression in gastric cancer cell lines could enhance the antitumour activity of T cells. In conclusion, this study reveals that RNF43 can inhibit PD‐L1 expression to enhance the antitumour activity of cellular immunotherapy.

Publisher

Wiley

Subject

Immunology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3